2024 Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years Group Lymphoma Working Party (LWP) 1st listed author Philipp Berning Journal Blood Cancer J.
2024 Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group Group Autoimmune Diseases Working Party (ADWP) Patient Advocacy Committee Nursing Research Committee Nursing Scientific Committee 1st listed author Tobias Alexander Journal J Allergy Clin Immunol Glob.
2024 Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Gesine Bug Journal Bone Marrow Transplant.
2024 How risky is a second allogeneic stem cell transplantation? Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Leukemia.
2024 Patient engagement in hematopoietic stem cell transplantation and cell therapy: a survey by the EBMT patient engagement task force & transplantation complications working party Group Transplant Complications Working Party (TCWP) Patient Advocacy Committee 1st listed author Hélène Schoemans Journal Bone Marrow Transplant.
2024 Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT Group Autoimmune Diseases Working Party (ADWP) Chronic Malignancies Working Party (CMWP) 1st listed author Carmelo Gurnari Journal Blood Adv.
2024 Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide versus conventional anti-graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Am J Hematol.
2024 Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party Group Acute Leukemia Working Party (ALWP) 1st listed author Jean El Cheikh Journal Bone Marrow Transplant.
2024 Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation Group Transplant Complications Working Party (TCWP) 1st listed author Olaf Penack Journal Haematologica.
2024 Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patient Group Acute Leukemia Working Party (ALWP) 1st listed author Ann-Kristin Schmälter Journal Blood Cancer J.
2024 Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) Global Committee 1st listed author Yishan Ye Journal Blood Cancer J.
2024 Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee Group Chronic Malignancies Working Party (CMWP) Practice Harmonisation and Guidelines Committee 1st listed author Donal P McLornan Journal Leukemia.